Takeda Pharmaceutical has a robust drug discovery pipeline to meet future clinical demand. Check out the upside and downside ...

A major Japanese labour union group said on Thursday its member unions had struck agreements for substantial wage hikes, ...

A major Japanese labour union group said on Thursday its member unions had struck agreements for hefty wage hikes with ...

NICE estimates that 1,000 women could benefit from Ryeqo, which can be taken once-daily up until the menopause.

AC Immune SA (NASDAQ: ACIU), a clinical-stage biopharmaceutical company pioneering precision therapeutics for neurodegenerative diseases, today reported results for the full year ended December 31, ...

Takeda’s revamped R&D strategy means the drugmaker’s oncology leaders are prioritizing work in tumors across thoracic, gastrointestinal (GI) and hematology, while pushing the Japanese company’s cell ...

Gedeon Richter's drug is the only licensed GnRH antagonist option and, unlike GnRH agonists like Takeda's Prostap ...

A cohort study of over 40,000 patients suggests that levels should be monitored for at least three months — longer than commonly practiced ...

Reports FY24 revenue $27.3M, consensus $26.97M. Dr. Andrea Pfeifer, CEO of AC Immune (ACIU) SA, commented: “We significantly advanced our ...

Novel Modes of Treatment and Drugs Spur the Demand in the Immuno-oncology Market: Fact Report ROCKVILLE, MD, UNITED STATES, March 13, ...

PharmaCord has about 1,100 employees, while Mercalis has about 1,800 with a high percentage of its employees based in the ...